Please login to the form below

Not currently logged in

animal health

This page shows the latest animal health news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s head of pharma heads for the exit

Boehringer’s head of pharma heads for the exit

The reshuffle is extending into other business units as well, with Joachim Hasenmaier - board member with responsibility for both animal and consumer health - stepping down after 18 years with the company. ... Hasenmaier will also retire by the end of

Latest news

More from news
Approximately 13 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The Bernstein analyst, Wimal Kapada, suggested recently that Bayer’s animal health division could be for sale or be spun out. ... So two opportunities here – acquisition of animal health products and out-licensing to Bayer’s pharma business.

  • Deal Watch February 2017 Deal Watch February 2017

    There were six deals worth more than $1bn this month: three focused on medtech, two on ethical pharmaceuticals and one in nutrition/ consumer health. ... animal health business (Merial) for Boehringer Ingelheim's consumer healthcare business.

  • Deal Watch October 2016 Deal Watch October 2016

    For Lilly this is a good deal as it acquired the Novartis Animal Health business for $4.5bn last year and Elanco, its animal health business, is now said to be ... one of the top three animal health companies.

  • Deal Watch May 2016 Deal Watch May 2016

    It is thought that Bayer can run to as much as $140 per share and rumours are abounding about a sale of its animal health interests to support the acquisition. ... This would be in line with the long standing advice of build up or exit for Bayer's animal

  • The human perspective The human perspective

    The latter deal will see Boehringer hand its consumer health interests to Sanofi in return for the French pharma firm's animal health arm Merial.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    He has held several positions at Pfizer including general manager of the company’s established products business unit and area president for its animal health business across the EMEA regions. ... Pfizer has also promoted John Young, current group

  • Bayer appoints head of EU liaison office Bayer appoints head of EU liaison office

    Prior to his role at the IVA, Halling was responsible for communications and public relations at the International Federation for Animal Health.

  • Dr George Gunn moves from Novartis to join Nuritas Dr George Gunn moves from Novartis to join Nuritas

    Dr Gunn joins from Novartis where he acted as head of the company's animal health division and as a member of its global executive committee from 2004 until early last ... year. Prior to this, he also served as division head for consumer health and head

  • Merck KGaA 'to promote' Stefan Oschmann to chief executive Merck KGaA 'to promote' Stefan Oschmann to chief executive

    Prior to joining MSD Oschmann worked for the International Atomic Energy Agency IAEA from 1985 to 1987 and for the German Animal Health Federation (BfT) from 1987 to 1989.

  • Merck KGaA’s Oschmann elected president of IFPMA Merck KGaA’s Oschmann elected president of IFPMA

    Oschmann has worked in life sciences for several decades, including roles early in his career at the German Animal Health Federation and the German Chemical Industry Association. ... Oschmann said he was honoured to take over the role at an important

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • 3 Monkeys Zeno shortlisted for 6 CIPR Excellence Awards

    Get Tested campaign. Through influencer relations we ignited a conversation around sexual health amongst young people to increase awareness of the importance of STI testing. ... the Year categories, for work in sexual health and animal health respectively

  • Random42 Attending Jefferies 2018 London Healthcare Conference

    The event will feature leading public and private companies from the pharmaceutical, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from all over the world.


    Our diverse experience in human and animal health includes:. gastroenterology. rheumatology. ... Marketing Manager, Animal Health.---"Of all the campaigns I've worked on, this has been the smoothest-run.

  • VCCP Health Appoints New Creative Team

    VCCP Health has announced the appointment of a new creative team: Sadie Mayes (Art Director) and Tess Evans (Creative Copywriter). ... Not only do they bring experience working on Rx accounts such as the immunology biosimilar portfolio for Novartis, but


    Corrina Safeio, Head of Planning and Research who led the development of CHANGE, says: “N owhere is behaviour change more relevant than in health. ... Max Macgregor, Product Manager at Bayer Animal Health agrees: “Working through the CHANGE model

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...